España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Acelyrin
SLRN
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$5.00
0.32
6.73%
Last update: 3:41 PM
15 minutes delayed
Get Report
Watch
Acelyrin (SLRN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Acelyrin (NASDAQ:SLRN) Stock
Acelyrin Stock (NASDAQ: SLRN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 08, 2024
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
ACELYRIN shares are trading higher after Well...
Benzinga Newsdesk
Wells Fargo Upgrades Acelyrin to Overweight, ...
Benzinga Newsdesk
Wednesday, May 22, 2024
HC Wainwright & Co. Maintains Buy on Acelyrin...
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Acelyri...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Maintains Buy on Acelyrin...
Benzinga Newsdesk
ACELYRIN Founder Shao-Lee Lin Steps Down As C...
Benzinga Newsdesk
Monday, April 01, 2024
HC Wainwright & Co. Reiterates Buy on Acelyri...
Benzinga Newsdesk
Friday, March 29, 2024
Acelyrin Q4 EPS $(0.75) Beats $(0.99) Estimat...
Benzinga Newsdesk
Thursday, March 21, 2024
Wells Fargo Maintains Equal-Weight on Acelyri...
Benzinga Newsdesk
Wednesday, March 20, 2024
Investors Cheer Acelyrin's Stock, Its Second Lead Candidate Shows Clinical Benefit In Thyroid Eye Disease Patients
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Acelyri...
Benzinga Newsdesk
Acelyrin shares are trading higher after data...
Benzinga Newsdesk
Acelyrin's Phase 1/2 Data For Lonigutamab In ...
Benzinga Newsdesk
Tuesday, March 12, 2024
HC Wainwright & Co. Reiterates Buy on Acelyri...
Benzinga Newsdesk
Monday, March 11, 2024
Acelyrin shares are trading higher after the ...
Benzinga Newsdesk
Acelyrin's Lead Drug Candidate Hits Primary Goal In Late-Stage Psoriatic Arthritis Study
Vandana Singh
Acelyrin Announces Top-line Results From Its ...
Benzinga Newsdesk
Acelyrin Announces Long-term 32-week Data Fro...
Benzinga Newsdesk
Wednesday, December 13, 2023
Wells Fargo Initiates Coverage On Acelyrin wi...
Benzinga Newsdesk
Friday, December 08, 2023
Citigroup Initiates Coverage On Acelyrin with...
Benzinga Newsdesk
Wednesday, November 29, 2023
Morgan Stanley Maintains Equal-Weight on Acel...
Benzinga Newsdesk
Tuesday, November 28, 2023
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Jefferies Maintains Buy on Acelyrin, Lowers P...
Benzinga Newsdesk
Acelyrin shares are trading lower after the c...
Benzinga Newsdesk
Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today?
Vandana Singh
What 5 Analyst Ratings Have To Say About Acelyrin
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Acelyri...
Benzinga Newsdesk
Monday, November 27, 2023
ACELYRIN Plans To Determine The Best Path For...
Benzinga Newsdesk
ACELYRIN Says Team Recently Identified Execut...
Benzinga Newsdesk
Wednesday, November 08, 2023
Acelyrin shares are trading lower after the c...
Benzinga Newsdesk
Tuesday, November 07, 2023
Acelyrin Q3 EPS $(0.87) Misses $(0.47) Estima...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, September 13, 2023
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
ACELYRIN shares are trading lower after Morga...
Bill Haddad
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
Benzinga Insights
Morgan Stanley Downgrades Acelyrin to Equal-W...
Benzinga Newsdesk
Tuesday, September 12, 2023
Despite Trial Setback For Acelyrin's Lead Program, Analyst Shows Optimism
Vandana Singh
Crude Oil Rises 2%; Avalo Therapeutics Shares Spike Higher
Lisa Levin
Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Dow Turns Higher; Oracle Shares Tumble After Q1 Results
Lisa Levin
DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories
Vandana Singh
Dow Falls 75 Points; US Small Business Optimism Drops In August
Lisa Levin
Why Is Skin Disorders Focused Acelyrin Stock Trading Lower Today?
Vandana Singh
Why Matrix Service Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Lisa Levin
HC Wainwright & Co. Reiterates Buy on Acelyri...
Benzinga Newsdesk
Acelyrin shares are trading lower after the c...
Benzinga Newsdesk
Oracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch